Drug Discovery 2022: driving the next life science revolution

Mario Richter

 Mario Richter
Mario Richter
Director II DMPK-BA
AbbVie Deutschland GmbH & Co. KG

Presentations at Drug Discovery 2022: driving the next life science revolution

Wed5  Oct11:00am(110 mins)

Session: Advancements in Screening and Automation Sponsored by IDBS
Room: Auditorium 3

Profile of Mario Richter

Mario is a Director in the DMPK-BA department at AbbVie serving as the global lead for biomarker work in the department across the therapeutic areas.
He is passionate about laboratory automation and always thinking about how to leverage it to spur innovation. In his 12 years at AbbVie he has helped establishing
the first fully automated GLP regulated lab for large molecule bioanalysis in the industry.
Mario is a biochemist and completed his PhD in epigenetics at the IMP Vienna in the lab of Thomas Jenuwein.
He is this year’s chair of the European scientific program committee of the SLAS.


Please login to send a Private Message

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'